Physician profile

Andrew Pollard

Cardiovascular Disease · Cincinnati, OH

NPI 1386184752

$2,755.49

in general payments reported to CMS, 2019-2025

15 companies · $427 in 2025

The $427 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,056.05

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $708.67 2020-2025 Watchman Access System, Watchman Flx
Abbott Laboratories $392.81 2020-2022
Astrazeneca Pharmaceuticals LP $362.72 2019-2022
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $213.21 2023-2025 Lifevest
Amgen INC. $199.43 2021-2023 Repatha
Edwards Lifesciences Corporation $198.99 2025 Sapien 3 Ultra Resilia
E.R. Squibb & Sons, L.L.C. $196.70 2019-2022
Heartflow, INC. $132.63 2023-2025 Ffrct
Lantheus Medical Imaging, INC. $124.65 2021
Boehringer Ingelheim Pharmaceuticals, INC. $89.38 2021-2025 Jardiance
Irhythm Technologies, INC. $35.69 2023-2024 Zio Xt Patch, Zio Monitor
Imperative Care, INC $33.86 2025 Symphony Catheter
Novartis Pharmaceuticals Corporation $31.31 2024-2025
Vital Connect, INC $18.99 2025 Vitalpatch Rtm
Inspire Medical Systems, INC. $16.45 2025 Inspire

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Andrew Pollard

$2,755.49

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $427 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/5705970/andrew-pollard

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.